Industry News
Stay up-to-speed with our monthly round-up of the latest developments from across the industry.
If you would like to receive updates via our newsletter then please sign up here.
Haemostasis November & December 2024 Industry News
Our round-up of the latest developments from across the haemostasis industry for November & December 2024, including key readouts at ASH2024 REGULATORY Vaderis Therapeutics’ VAD044 (AKT inhibitor) granted FDA Fast Track designation for the treatment of Hereditary Haemorrhagic Telangiectasia (HHT) (18 Nov) Kedrion Biopharma announced that the FDA approved the company’s manufacturing facility in Bolognana, […]
Haemostasis October 2024 Industry News
Stay up-to-speed with our monthly round-up of the latest developments from across the haemostasis industry.
